VENETOCLAX

venetoclax 10 mg tablet, 2

VENETOCLAX (12999E)

venetoclax 10 mg tablet, 2
12999E
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Dose modification
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 7 Max qty units: 14 # of repeats: 0 DPMQ: $104.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta